Nissan Medical Industries Ltd (TLV:NISA)
Israel · Delayed Price · Currency is ILS · Price in ILA 900.70
+1.40 (0.16%)
Sep 2, 2026, 5:24 PM IDT
Nissan Medical Industries Ratios and Metrics
Market cap in millions ILS. Fiscal year is January - December.
Millions ILS. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 82 | 83 | 116 | 98 | 78 | 199 | |
Market Cap Growth | -21.40% | -28.12% | 18.15% | 25.68% | -60.78% | -23.34% |
Enterprise Value | 356 | 363 | 413 | 431 | 433 | 525 |
Last Close Price | 9.01 | 9.17 | 10.78 | 8.67 | 6.90 | 17.26 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 11.81 | 19.97 | 14.66 | 17.37 | - | 5.53 |
PS Ratio | 0.13 | 0.13 | 0.18 | 0.13 | 0.11 | 0.30 |
PB Ratio | 0.28 | 0.27 | 0.33 | 0.28 | 0.24 | 0.58 |
P/TBV Ratio | 0.55 | 0.53 | 0.60 | 0.51 | 0.44 | 1.18 |
P/FCF Ratio | 2.59 | 2.28 | 5.59 | 1.02 | 31.30 | 20.27 |
P/OCF Ratio | 1.29 | 1.33 | 4.32 | 0.93 | 6.69 | 11.07 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 0.59 | 0.56 | 0.62 | 0.59 | 0.63 | 0.79 |
EV/EBITDA Ratio | 6.64 | 7.49 | 7.79 | 4.66 | 16.09 | 5.75 |
EV/EBIT Ratio | 12.91 | 14.08 | 13.92 | 7.02 | - | 7.98 |
EV/FCF Ratio | 11.27 | 9.94 | 19.91 | 4.49 | 173.44 | 53.48 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.61 | 0.62 | 0.57 | 0.56 | 0.76 | 0.70 |
Debt / EBITDA Ratio | 3.32 | 3.54 | 3.41 | 2.14 | 9.34 | 2.63 |
Debt / FCF Ratio | 5.66 | 5.20 | 9.76 | 2.07 | 100.67 | 24.53 |
Net Debt / Equity Ratio | 0.56 | 0.56 | 0.52 | 0.49 | 0.70 | 0.58 |
Net Debt / EBITDA Ratio | 3.38 | 3.55 | 3.50 | 1.87 | 8.61 | 2.20 |
Net Debt / FCF Ratio | 5.21 | 4.71 | 8.93 | 1.81 | 92.85 | 20.44 |
Asset Turnover | 0.97 | 0.99 | 0.94 | 1.02 | 0.93 | 0.93 |
Inventory Turnover | 4.28 | 3.98 | 3.98 | 5.40 | 5.66 | 6.44 |
Quick Ratio | 0.46 | 0.44 | 0.38 | 0.62 | 0.66 | 0.74 |
Current Ratio | 0.98 | 0.99 | 1.11 | 1.16 | 1.17 | 1.34 |
Return on Equity (ROE) | 4.56% | 2.63% | 3.89% | 5.54% | -13.99% | 17.11% |
Return on Assets (ROA) | 2.77% | 2.44% | 2.62% | 5.32% | -0.15% | 5.75% |
Return on Invested Capital (ROIC) | 5.07% | 4.39% | 5.06% | 7.70% | -0.32% | 10.07% |
Return on Capital Employed (ROCE) | 7.30% | 6.50% | 6.50% | 12.70% | -0.30% | 12.20% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 8.88% | 5.01% | 6.82% | 5.76% | -46.18% | 18.09% |
FCF Yield | 38.62% | 43.84% | 17.90% | 97.75% | 3.19% | 4.93% |
Dividend Yield | 21.98% | 19.84% | 6.96% | - | - | 2.55% |
Payout Ratio | 227.46% | 396.17% | 86.17% | - | - | 25.22% |
Total Shareholder Return | 12.54% | 19.84% | 6.96% | - | - | 2.55% |